5.0793
Precedente Chiudi:
$5.02
Aprire:
$5.05
Volume 24 ore:
21,627
Relative Volume:
0.04
Capitalizzazione di mercato:
$8.05M
Reddito:
-
Utile/perdita netta:
$-14.58M
Rapporto P/E:
-4.4168
EPS:
-1.15
Flusso di cassa netto:
$-9.80M
1 W Prestazione:
-24.78%
1M Prestazione:
+9.11%
6M Prestazione:
-39.85%
1 anno Prestazione:
-86.65%
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Nome
Acurx Pharmaceuticals Inc
Settore
Industria
Telefono
917-533-1469
Indirizzo
259 LIBERTY AVENUE, STATEN ISLAND
Confronta ACXP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ACXP
Acurx Pharmaceuticals Inc
|
5.0793 | 10.45M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.00 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.70 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.76 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.09 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Acurx Pharmaceuticals Inc Borsa (ACXP) Ultime notizie
How resilient is Acurx Pharmaceuticals Inc. stock in market downturnsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
Can Acurx Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Performance Report & Weekly Sector Rotation Insights - newser.com
Will Acurx Pharmaceuticals Inc. (3ZO) stock draw ESG focused fundsMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock overpriced at current multiplesJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
How strong is Acurx Pharmaceuticals Inc. (3ZO) stock earnings growthWeekly Trend Report & Fast Gain Stock Tips - newser.com
Can Acurx Pharmaceuticals Inc. stock sustain free cash flow growth2025 Price Momentum & Weekly High Return Forecasts - newser.com
Pattern recognition hints at Acurx Pharmaceuticals Inc. upsideGold Moves & Free Safe Capital Growth Stock Tips - newser.com
Why Acurx Pharmaceuticals Inc. stock appeals to analystsWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Will Acurx Pharmaceuticals Inc. stock outperform growth indexesMarket Trend Summary & Daily Oversold Stock Bounce Ideas - newser.com
What dividend safety score for Acurx Pharmaceuticals Inc. stockWeekly Stock Summary & Technical Buy Zone Confirmations - newser.com
Combining price and volume data for Acurx Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com
Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Grows By 82.1% - Defense World
How supply shortages influence Acurx Pharmaceuticals Inc. (3ZO) stock2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Multi factor analysis applied to Acurx Pharmaceuticals Inc.Recession Risk & Accurate Buy Signal Notifications - newser.com
What risks investors should watch in Acurx Pharmaceuticals Inc. stock2025 Market Outlook & Daily Profit Maximizing Trade Tips - newser.com
Can swing trading help recover from Acurx Pharmaceuticals Inc. lossesPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding - GlobeNewswire Inc.
Can Acurx Pharmaceuticals Inc. (3ZO) stock test all time highsBuy Signal & Fast Exit/Entry Strategy Plans - newser.com
Comparing Acurx Pharmaceuticals Inc. in custom built stock radarsDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Can Acurx Pharmaceuticals Inc. stock sustain market leadershipTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
Acurx Pharmaceuticals’ Ibezapolstat: Promising Preclinical and Clinical Efficacy Supports Buy Rating - TipRanks
Will Acurx Pharmaceuticals Inc. stock split attract more investors2025 Analyst Calls & Technical Pattern Alert System - newser.com
Is Acurx Pharmaceuticals Inc. stock recession proofQuarterly Profit Report & Expert Approved Momentum Ideas - newser.com
Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans - MSN
Acurx Announces Phase 3-Ready Ibezapolstat Data at IDWeek 2025 | ACXP Stock News - Stock Titan
Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):